Medpace Holdings, Inc. (MEDP)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$411.60
-2.34%
Mkt Cap $14.70B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 22, 2026 | $697.60M | $706.60M | +1.29% | $3.92 | $4.28 | +9.18% | — | — |
| Q1 2026 Feb 9, 2026 | $689.31M | $708.45M | +2.78% | $4.19 | $4.67 | +11.46% | — | — |
| Q4 2025 Oct 22, 2025 | $641.00M | $659.90M | +2.95% | $3.53 | $3.86 | +9.35% | — | — |
| Q3 2025 Jul 21, 2025 | $538.77M | $603.31M | +11.98% | $2.98 | $3.10 | +4.03% | — | — |
| Q2 2025 Apr 21, 2025 | $526.34M | $558.57M | +6.12% | $3.06 | $3.67 | +19.93% | — | — |
| Q1 2025 Feb 10, 2025 | $539.74M | $536.59M | -0.58% | $2.96 | $3.67 | +23.99% | — | — |
| Q4 2024 Oct 21, 2024 | $534.88M | $533.32M | -0.29% | $2.78 | $3.01 | +8.27% | — | — |
| Q3 2024 Jul 22, 2024 | $528.40M | $528.10M | -0.06% | $2.54 | $2.75 | +8.27% | — | — |
| Q2 2024 Apr 22, 2024 | $512.39M | $511.04M | -0.26% | $2.47 | $3.20 | +29.55% | — | — |
| Q1 2024 Feb 12, 2024 | $512.06M | $498.40M | -2.67% | $2.22 | $2.46 | +10.81% | — | — |
| Q4 2023 Oct 23, 2023 | $475.75M | $492.50M | +3.52% | $2.05 | $2.22 | +8.29% | — | — |
| Q3 2023 Jul 24, 2023 | $448.29M | $460.87M | +2.81% | $1.91 | $1.93 | +1.05% | — | — |
| Q2 2023 Apr 24, 2023 | $419.76M | $434.07M | +3.41% | $1.80 | $2.27 | +26.11% | — | — |
| Q1 2023 Feb 13, 2023 | $386.01M | $394.10M | +2.09% | $1.79 | $2.12 | +18.44% | — | — |
| Q4 2022 Oct 24, 2022 | $357.17M | $383.74M | +7.44% | $1.47 | $2.05 | +39.46% | — | — |
| Q3 2022 Jul 25, 2022 | $344.01M | $351.21M | +2.09% | $1.31 | $1.46 | +11.45% | — | — |
| Q2 2022 Apr 25, 2022 | $327.09M | $330.95M | +1.18% | $1.26 | $1.69 | +34.13% | — | — |
| Q1 2022 Feb 14, 2022 | $309.04M | $308.55M | -0.16% | $1.25 | $1.32 | +5.60% | — | — |
| Q4 2021 Oct 25, 2021 | $292.15M | $295.57M | +1.17% | $1.07 | $1.29 | +20.56% | — | — |
| Q3 2021 Jul 26, 2021 | $292.15M | $278.29M | -4.74% | $0.99 | $1.06 | +7.07% | — | — |